Subic 'drug user' killed inside own home | Inquirer News

Subic ‘drug user’ killed inside own home

By: - Correspondent / @amacatunoINQ
/ 10:26 PM August 15, 2016

Shooting victim (FILE PHOTO BY RAY ZAMBRANO/INQUIRER NORTHERN LUZON)

Shooting victim (FILE PHOTO BY RAY ZAMBRANO/INQUIRER NORTHERN LUZON)

SUBIC, Zambales  — A man, who had confessed his drug habits to the police, was shot dead as he slept in his house on Monday (Aug. 15).

Orlando Dominguez, 51, a resident of Barangay (village) Ilwas here, was killed by two gunmen who, witnesses said, were seen roaming around the victim’s house at about 4 a.m., said SPO4 George Cruz, investigator at the Subic police station.

Article continues after this advertisement

Police said Dominguez was among the 1,450 confessed drug dependents who surrendered to authorities here under the government’s Oplan Tokhang, a nationwide anti-drug campaign that has been encouraging drug dealers and users to voluntarily surrender to the police.

FEATURED STORIES

Citing witnesses’ accounts, Cruz said the gunmen barged into Dominguez’s house and shot the victim.

Investigators recovered from the crime scene a 9mm live bullet, four pieces of spent shells fired from a 9mm pistol, and several drug paraphernalia.  SFM

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Crime, drug pushing, Drug trafficking, drug trafficking suspect, drug use, drug user, Murder, News, Oplan Tokhang, Police, purge, Regions, rubout, seizure, Shooting, Zambales

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.